1. 使用快速、有效的共同培养模式来评估商业可购的乳酸杆菌菌株之抗发炎及屏障强化能力。

    Use of a fast and efficient co-culture model to evaluate anti-inflammatory and barrier-reinforcing effects of commercial Lactobacillus strains. The 6th Congress of Asian Society for Pediatric Research & 51st Annual Meeting Of Taiwan Pediatric Association, April 15-18, 2010. 
2. 评估鼠李糖乳杆菌作为附加疗法治疗多年生过敏性鼻炎儿童（7-12岁）的有效性和安全性：一个为期8周、随访4周、双盲、随机的安慰剂对照研究。

    Evaluation of Efficacy and Safety of Lactobacillus rhamnosus as an Add-on Therapy in Children(7-12 Years Old) with Perennial Allergic Rhinitis: An 8 Weeks, Double-blind, Randomized, Placebo-controlled Study with a 4-week Follow-up. ISSN 1608-8115 ACTA PAEDIATRICA TAIWANICA, November 2012, Vol. 53, Supplement. 
3. 评估鼠李糖乳杆菌在4个月到4岁异位性皮肤炎的病童的有效性及安全性：一个为期8周、双盲、随机的安慰剂对照研究。

    Evaluation of Efficacy and Safety of Lactobacillus rhamnosus in Children Aged 4-48 Months with Atopic Dermatitis: A 8-Week, Double-Blind, Randomized, Placebo-Controlled Study. 2013 台湾儿科医学会 第二一四届学术演讲会 – 44 
4. 双歧杆菌与鼠李糖乳杆菌三联活菌制剂联合治疗小儿轮状病毒肠炎的疗效及对免疫功能的影响。

    Clinical effects for patients with rotaviral enteritis by Bifidobacterium combined with Lactobacillus rhamnosus and the influence on the immune function. Medical Innovation of China 2016 Vol.13, No.6 p.59-61. 
5. 补充双歧杆菌与鼠李糖乳杆菌三联活菌制剂对肠道手术后肠道菌群的影响。

    Effects of supplemented Bifidobacterium and Lactobacillus acidophilus triple living bacteria preparation on intestinal flora after intestinal surgery. CHINA MODERN MEDICINE Vol. 24 No. 5 February 2017. 
6. 活性益生菌治疗过敏性鼻炎的临床观察及免疫调节作用分析。

    Clinical observation of active probiotics in the treatment of allergic rhinitis and analysis of its effect on immunoregulation. CHINA MODERN DOCTOR Vol. 55 No. 5 February 2017. 
7. 鼠李糖乳杆菌对4-48个月异位性皮肤炎孩童的疗效和安全性评估。

    Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study. Journal of Microbiology, Immunology and Infection. Volume 50, Issue 5, October 2017, p. 684-692
8. 婴儿早期应用乳酸杆菌四联菌对预防过敏性疾病的临床研究。

    A clinical study on early application of lactobacillus tetravaccine in preventing allergic diseases of infants. Practical Journal of Clinical Medicine Vol.15 No.4 July 2018. 
9. 鼠李糖乳杆菌MP108之安全性评估。

    Lactobacillus rhamnosus MP108: Toxicological evaluation. J Food Sci. 2021 Jan;86(1):228-241

1. 评估Lactobacillus paracasei胶囊作为儿童常年型过敏性鼻炎辅助治疗的有效性及安全性-一为期12周双盲随机安慰组对照试验。

    Evaluation of Efficacy and Safety of Lactobacillus Paracasei Capsule as an Add-on Therapy in Children(6-13 Years Old) with Perennial Allergic Rhinitis: A 12-week, Double-blind, Randomized, Placebo-Controlled Study. 2012 台湾儿科医学会杂志 – 32

2. 评估Lactobacillus paracasei胶囊作为儿童常年型过敏性鼻炎辅助治疗的有效性及安全性-一为期12周双盲随机安慰组对照试验。

    Evaluation of the Effect of Lactobacillus paracasei (HF.A00232) in Children (6–13 years old) with Perennial Allergic Rhinitis: A 12-week, Double-blind, Randomized, Placebo-controlled Study[J]. Pediatrics & Neonatology, 2014, 55(3):181-188.

3. 婴儿早期应用乳酸杆菌四联菌对预防过敏性疾病的临床研究。

    A clinical study on early application of lactobacillus tetravaccine in preventing allergic diseases of infants. Practical Journal of Clinical Medicine Vol.15 No.4 July 2018. 

1. 热致死益生菌具有调节免疫的能力。

    Heat-killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization. Journal of Food Science 2011; Vol.76, Nr.5: p.M260-M267.
2. 藉细胞及动物模式验证益生菌在口腔与喉咙发炎调节的潜力。

    The potential for probiotics to modulate inflammatory of oral and throat by in vitro and animal model. The 6th Asian Conference on Lactic Acid Bacteria 2011; P-AM11-78.
3. 细胞实验证实益生菌可抑制病原体以保护人体黏膜组织。

    Inhibition of in vitro growth of pathogens to protect human mucosae by probiotics. The 7th International Symposium on Lactic Acid Bacteria and Health. 2012; P2-18.
4. 益生菌株具备可调节上皮细胞及免疫细胞发炎反应之能力。

    Potential of probiotic strains to modulate the inflammatory responses of epithelial and immune cells in vitro. New Microbiologica 2013; 36: p.167-179.
5. 不同乳酸菌代谢化合物对抗阴道病原菌之比较及其女性生殖道抗菌产品之开发。

    Comparison of the inhibition effect of lactic acid bacteria fermentation metabolites on different vaginal pathogens and developing gynecological probiotic products. CIFST. 2017.
6. 从发展妇科益生菌产品角度比较热致死乳酸菌在不同阴道致病菌的抑制效果。

   Inhibitory effects of viable and heat-killed lactic acid bacteria against different vaginal pathogens: toward development of gynecological probiotics. IUMS. 2017.
7. 应用乳酸菌来抑制鱼类致病菌生长并且改善水产养殖的饲料转化率。

    Applications of lactic acid bacteria to inhibit the growth of fish pathogens and improve the feed conversion rate in aquaculture. IUMS. 2017.
8. 唾液乳杆菌、嗜酸乳杆菌及植物乳杆菌三联活菌制剂联合三联疗法根除幽门螺杆菌的临床研究。

    Clinical study of Lactobacillus salivarius, Lactobacillus acidophilus and Lactobacillus plantarum triple viable capsules combined with triple therapy for Helicobacter pylori eradication.《中国医学创新》第14卷第10期（总第400 期）2017年4月。Medical Innovation of China. 2017; 14(10): p.036-039.
9. 益生菌冻干粉联合铋剂四联疗法治疗幽门螺旋杆菌感染的临床效果。

    Clinical effect of probiotics freeze-Dried Powder combined with bis-muth-containing quadruple therapy in the treatment of Helicobacter pylori infection. 《中国当代医药》2018年8月第25卷第23期 CHINA MODERN MEDICINE Vol. 25 No. 24 Aug. 2018. p.155-7.
10. 婴儿早期应用乳酸杆菌四联菌对预防过敏性疾病的临床研究。

     A clinical study on early application of lactobacillus tetravaccine in preventing allergic diseases of infants. PRACTICAL JOURNAL OF CLINICAL MEDICINE Vol. 15 No. 4 July 2018, p.71-3.

1. 益生菌保护人体黏膜以抑制致病菌生长。

    Inhibition of in vitro growth of pathogens to protect human mucosae by probiotics. CIFST. 2012; P2-18.
2. 两株双歧杆菌菌株可调节肥胖与脂肪分布。

    Effects of two novel Bifidobacteria strain on obesity and lipid levels. The 6th International Conference on Food Factors 2015; P-0483.
3. 活菌和热致死菌乳酸菌对不同阴道病原菌的抑制作用：发展妇科益生菌。

    Inhibitory effect of viable and heat-killed lactic acid bacteria against different vaginal pathogens : toward development of gynecological probiotics. 15th International Congress of Mycology and Eukaryotic Microbiology 2017; PO 287.
4. 应用乳酸菌抑制鱼类病原体的生长，提高水产养殖的饲料转化率。

    Applications of lactic acid bacteria to inhibit the growth of fish pathogens and improve the feed conversion rate in aquaculture. 15th International Congress of Mycology and Eukaryotic Microbiology 2017; PO 288.
5. 作用于口腔保健的益生菌优势功效与应用。

    Functional characterization and applicant of probiotic strains advantages on oral health care. The 13th international symposium on lactic acid bacteria and health 2018.
6. 益生菌对于体重控制的人群研究。

    Clinical research on the effects of probiotics on regulation of body weight. 14th Annual Meeting of Chinese Institute of Food Science and Technology, 2019 (CIFST) 
7. 乳酸菌对超广谱酶大肠杆菌(ESBL）之抑菌效果。

    Bacteriostatic activities of lactic acid bacteria against extended-spectrum β-lactamase(ESBL)-producing Escherichia coli. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):3-4.
8. 活乳酸菌与热灭活乳酸菌对乙型链球菌GBS之抑菌效果。

    Bacteriostatic abilities of viable and heat-killed lactic acid bacteria against group B Streptococcus. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):12-13.
9. 活乳酸菌与热灭活乳酸菌对抗药性金黄葡萄球菌(MRSA) 之抑菌效果。

    Assessment of bacteriostatic activities of viable and non-viable lactic acid bacteria against methicillin-resistant Staphylococcus aureus. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):14-15.
10. 活菌益生菌和热灭活益生菌对口腔病原菌抗菌功。

     Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens. Lett Appl Microbiol. 2020 Apr;70(4):310-317.